RESEARCH & DEVELOPMENT PARTNERS
Our novel drug development pipeline was built through collaborations with top University researchers, industry leaders in novel delivery and manufacturing processes, and respected hospitals who care about their patients.
Our intellectual property portfolio of complex therapeutic mixtures currently includes: 5 issued US patents and 3 issued international patents as well as 19 US and 40 international patent-pending applications.
University of Athens, Greece
Michigan State University
University of Seville, Spain
National Research Council, Canada
University of Cadiz,
University of Hawaii
Animal Models used for establishing a Proof-of-Concept for our Optimized Therapeutic Mixtures for the treatment of Heart Failure.
The University of
In Discussion – We are currently selecting partners for our First-in-Man studies.
LEAD INDICATIONS INCLUDE PARKINSON’S DISEASE AND NEUROPATHIC PAIN.
IF YOUR COMPANY IS INTERESTED IN TALKING WITH US ABOUT THESE OPPORTUNITIES, PLEASE FILL OUT THE FORM AT THE BOTTOM OF THIS PAGE.
Here’s the latest from Gb Sciences
Andrea Small-Howard, Ph.D.